Unlocking Protein Insights via Seamless Access to AI Models at Scale
- AI breakthroughs are revolutionizing drug discovery and molecular biology
- Research teams face practical barriers including fragmented toolsets, inconsistent infrastructure across cloud and on-premises environments, and complex interfaces hinder adoption by non-computational scientists
- In competitive drug discovery, speed to insight drives success